✦ LIBER ✦

Recurrence prevention in patients with recurrent major depression receiving 12 months of treatment with venlafaxine XR

✍ Scribed by M. Keller; B. Yan; J. Musgnung; D. Dunner; J. Ferguson; E. Friedman; A. Gelenberg; R. Hirschfeld; J. Kocsis; S. Kornstein; C. Nemeroff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.019 Two-year maintenance treatment

✍ M. Keller; B. Yan; D. Dunner; J. Ferguson; E. Friedman; A. Gelenberg; R.M.A. Hir 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Two-year placebo-controlled maintenance

✍ M. Keller; B. Yan; J. Musgnung; D. Dunner; J. Ferguson; E. Friedman; A. Gelenber 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 46 KB

Two years of maintenance treatment with

✍ J.H. Kocsis; S.G. Kornstein; S. Ahmed; T. Ferdousi; J. Musgnung; M. Thase; E. Fr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 62 KB

The cost-utility of maintenance treatmen

✍ P. Sobocki; M. Ekman; A. Ovanfors; R. Khandker; B. Jönsson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

Venlafaxine XR is superior to placebo in

✍ L. Aguiar; R. Entsuah; D. Lei; R. Rudolph 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Treatment-resistant residual insomnia in

✍ Shinobu IWAKI; Kohtoku SATOH; Yasuhiro MATSUMOTO; Masaru ECHIZENYA; Tomonori KAT 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB